Quantitative Proteomic Analysis Reveals That Luks-Pv Exerts Antitumor Activity by Regulating the Key Proteins and Metabolic Pathways in HepG2 Cells

Anti-Cancer Drugs - United States
doi 10.1097/cad.0000000000000866
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Ovid Technologies (Wolters Kluwer Health)


Related search